Sinovac Biotech Receives $500 Million in Funding for COVID-19 Vaccine Manufacturing
The company has received $500 million in funding from Sino Biopharmaceutical for further development, capacity expansion, and manufacturing of CoronaVac, its COVID-19 vaccine candidate. Sinovac Biotech, a biopharmaceutical products provider in ...
from Google Alert - Business https://ift.tt/2W04NoE
The company has received $500 million in funding from Sino Biopharmaceutical for further development, capacity expansion, and manufacturing of CoronaVac, its COVID-19 vaccine candidate. Sinovac Biotech, a biopharmaceutical products provider in ... https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/2W04NoE
The company has received $500 million in funding from Sino Biopharmaceutical for further development, capacity expansion, and manufacturing of CoronaVac, its COVID-19 vaccine candidate. Sinovac Biotech, a biopharmaceutical products provider in ... https://ift.tt/eA8V8J
Comments
Post a Comment